Simplify Asset Management Inc.
Source: SEC Form 13F · as of Mar 2026Simplify Asset Management Inc. holds 24 biotech & pharma companies tracked by BioSniper, totaling $54.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
24
Total value held
$54.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Jazz Pharmaceuticals plc (JAZZ)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| JAZZJazz Pharmaceuticals plc | 51,730 | $9.8M |
| GILDGILEAD SCIENCES, INC. | 61,345 | $8.5M |
| REGNREGENERON PHARMACEUTICALS, INC. | 10,900 | $8.4M |
| BHVNBiohaven Ltd. | 898,400 | $7.6M |
| ABEOABEONA THERAPEUTICS INC. | 507,988 | $2.3M |
| CLDXCelldex Therapeutics, Inc. | 68,994 | $2.2M |
| MISTMilestone Pharmaceuticals Inc. | 1,506,405 | $1.8M |
| INSMINSMED Inc | 10,783 | $1.8M |
| LONALeonaBio, Inc. | 149,279 | $1.5M |
| IVAInventiva S.A. | 227,923 | $1.3M |
| VRDNViridian Therapeutics, Inc.\DE | 56,231 | $1.1M |
| AQSTAquestive Therapeutics, Inc. | 234,279 | $972K |
| ZVRAZEVRA THERAPEUTICS, INC. | 100,630 | $938K |
| CMPSCOMPASS Pathways plc | 159,052 | $880K |
| OCULOCULAR THERAPEUTIX, INC | 90,000 | $762K |
| SABSSAB BIOTHERAPEUTICS, INC. | 187,230 | $717K |
| UPBUpstream Bio, Inc. | 77,793 | $700K |
| FDMT4D Molecular Therapeutics, Inc. | 70,430 | $656K |
| TGTXTG THERAPEUTICS, INC. | 16,049 | $533K |
| KLRSKalaris Therapeutics, Inc. | 87,426 | $504K |
| IMUXIMMUNIC, INC. | 438,932 | $487K |
| CHRSCoherus Oncology, Inc. | 253,140 | $428K |
| OVIDOvid Therapeutics Inc. | 130,813 | $290K |
| CYPHCYPHERPUNK TECHNOLOGIES INC. | 21,139 | $17K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.